ALAlvotech ALVO · NASDAQ
$5.31 +2.71% (+$0.14)
- Market cap
- $1.89B
- Enterprise value
- $3.20B
- P/E
- -
- Forward P/E
- -
- PEG
- -
- P/S
- 3.9x
- P/FCF
- -
- EV/EBITDA
- -
- ROIC
- 20.2%
- Bruto marža
- 60.4%
- Neto marža
- -36.5%
- Dividend yield
- -
- Payout ratio
- -
- Neto dolg/EBITDA
- -
- Beta
- 0.18
- Free float
- 30.5%
O podjetju
Alvotech (ALVO) is a fully integrated specialty biopharmaceutical company focused exclusively on the development and manufacture of high-quality biosimilar medicines. The company's goal is to improve patients' health and quality of life around the world by increasing access to effective therapies for various ailments.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Lisa Graver
Employees
1,279
Headquarters
Luxembourg
Vrednotenje
Je današnja cena primerna?
Rast in ocene
Ali podjetje raste in kaj sledi?
Donosnost in kakovost
Koliko prihodkov ostane in kako dobro podjetje uporablja kapital?
Finančno zdravje
Ali zmore svoj dolg?
Kapital in dividende
Kaj podjetje počne z zasluženim denarjem?
Analitiki
Kaj menijo strokovnjaki in ali se to spreminja?
Lastniki in insajderji
Kdo ima delnice in kaj počne vodstvo?
Segmenti
Kateri del podjetja raste?
Primerjava s konkurenco
Kako se primerja s podobnimi podjetji?
Cena in tveganje
Kako se delnica obnaša?
Izkazi
Vse številke